A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

Overview of attention for article published in Neurology, March 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 2 X users

patent: 34 patents

Readers on

mendeley: 72 Mendeley

So far, Altmetric has seen 34 patents that reference this research output.

Anti-VLA-4 related assays

Grant US-12385925-B2

United States of America

12 Aug 2025

Methods and products for evaluating an immune response to a therapeutic protein

Grant US-11686734-B2

United States of America

27 Jun 2023

Anti-VLA-4 related assays

Grant US-11280793-B2

United States of America

22 Mar 2022

Administration of agents for the treatment of inflammation

Grant US-11248051-B2

United States of America

15 Feb 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 30 additional patents.